FTSE China A50 index futures opened 0.80% lower, and closed down 0.89% in the last session.The United States ITC officially launched a 337 investigation on injection molding machines, their components and downstream products. According to China Trade Relief Information Network, on December 12, the United States International Trade Commission (ITC) voted to launch a 337 investigation (investigation code: 337-TA-1427) on specific injection molding machines, their components and downstream products.Affected by martial law, the support rate of South Korean President Yin Xiyue fell to a record 11%.
FTSE China A50 index futures opened 0.80% lower, and closed down 0.89% in the last session.The game and media sectors moved up three boards in vision china, three boards in vision china, Fuchun, Reader Media, Zhewen Internet and Guangdong Media, and Kaiying Network, Shengguang Group and Tianlong Group followed suit.The central bank's open market today launched a 7-day reverse repurchase operation of 205.1 billion yuan, and the operating interest rate was flat at 1.50%. Today, 190.9 billion yuan of 7-day reverse repurchase expired, and the net investment on that day was 14.2 billion yuan.
Solar energy and other new companies have set up photovoltaic power generation equipment business. The enterprise search APP shows that recently, China Energy Saving Ledebao Solar Technology (Delingha) Co., Ltd. was established, with Du Hu as the legal representative and a registered capital of 1 million yuan. Its business scope includes: sales of solar thermal utilization equipment; Lease of photovoltaic power generation equipment; Ecological restoration and ecological protection services, etc. Enterprise investigation shows that the company is jointly owned by China Energy Saving Solar Technology Co., Ltd. and Qinghai Laidebao New Materials Co., Ltd., a wholly-owned subsidiary of solar energy.Shanghai Securities: The pharmaceutical and bio-industry is expected to further repair its performance and valuation. The Shanghai Securities Research Report pointed out that with the support of policies and the adjustment of the internal structure of the industry, the pharmaceutical and bio-industry is expected to further repair its performance and valuation. It is suggested to pay attention to five directions: 1) Innovative drugs (with strong national policy support, the payment terminal is expected to further improve and go to sea to occupy the global market); 2)CXO (the negative impact of the biosafety bill event has been eliminated, and the demand for orders in the superimposed interest rate reduction cycle has increased, which is expected to usher in a double repair of performance and valuation); 3) Imitation and innovation (centralized procurement is expected to clear up, increase innovation, and traditional pharmaceutical companies will usher in new opportunities); 4) Traditional Chinese Medicine (the national policy supports the innovation of traditional Chinese medicine, and its performance is expected to maintain a good growth rate); 5) Medical devices (equipment updating, high-consumption innovation, low-consumption going to sea, etc.). Individual stocks can be concerned about: Baekje Shenzhou, Wuxi PharmaTech, China Resources Sanjiu and so on.Wanwu Lianghang upgraded its real estate management with wisdom and low carbon. On December 12, Wanwu Lianghang released a smart+low carbon solution for real estate operation, relying on AI wisdom brain-Wanwu Yunlingshi to help asset holders carry out asset management, enterprise services, energy management and property supervision more efficiently and transparently.
Strategy guide 12-14
Strategy guide 12-14
Strategy guide 12-14